Bionostics

What Bionostics does

Bio-Techne (formerly Bionostics) is a US-based developer and manufacturer of quality control and calibration solutions for the in-vitro diagnostic (IVD) market, founded in 1981 in Acton, Massachusetts and now operating from a 45,000 square foot cGMP facility in Devens, Massachusetts. The company produces proprietary, device-specific aqueous, plasma, and serum-based controls, buffers, calibrators, and standards that are integral to OEM diagnostic devices and rely on FDA 510(k) approval, and it holds a portfolio of patents and trademarks covering its UniDose single-use foil packaging platform, Meter Check glucose controls, Safe-Wrap capillary blood collection tubes, and the PeerQC web-based interlaboratory peer statistics service. Its product portfolio is certified to ISO 13485:2016 and ISO 9001:2008, with regulatory clearances in 95 countries including US FDA Class I/II listings, Canadian Medical Device Licenses, and CE marking under IVD Directive 98/79/EC.

The company operates through two distinct go-to-market channels: an OEM supply channel that provides turnkey quality control and calibration products to virtually all global IVD device manufacturers for critical care, point-of-care, and diabetes diagnostics, and a direct-to-hospital channel via the RNA Medical subsidiary, which sells daily QC materials, calibration verification products, and blood collection tubes to hospitals and healthcare facilities. Bio-Techne (formerly Bionostics) was acquired by Techne Corporation (NASDAQ: TECH) in July 2013 for approximately $104 million and now operates as a wholly-owned subsidiary within Techne's Clinical Controls Division, with its own identity retained under the Bio-Techne brand alongside the legacy Bionostics trade name. Revenue is generated through OEM product sales (hardware/embedded), direct hospital sales of consumables, and a subscription-based web service (PeerQC), though standalone financial metrics are not publicly disclosed.

Name

Bionostics

Legal name

Bio-Techne Corporation

Website

https://bionostics.com

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

51–100 employees

Short description

Bio-Techne (formerly Bionostics) develops and manufactures proprietary quality control and calibration solutions for global IVD OEMs and hospitals, operating a 45,000 sq ft cGMP facility from Devens, Massachusetts, and serving IVD manufacturers in 95 countries through OEM supply and direct hospital sales.

Ownership category

akta.pro rank

Product category

IVD Quality Control Products

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL)

akta.pro secondary industry

Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)

Keywords

• IVD quality controls
• Diagnostic calibration products
• Clinical chemistry controls
• Point-of-care testing supplies
• Medical device OEM manufacturing

Headquarters

HQ city

Devens

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. OEM Quality Control Products: Development, manufacture and distribution of quality control solutions and calibrators to IVD OEMs for critical care, point-of-care and diabetes diagnostics test systems. Products are proprietary device-specific formulations integrated into OEM diagnostic devices.
2. RNA Medical Direct-to-Hospital Sales: Direct sales of quality control materials, calibration verification and linearity products, and blood collection tubes to hospitals and healthcare facilities through RNA Medical subsidiary.
3. PeerQC Interlaboratory Statistics Service: Web-based peer statistics service enabling diagnostic customers to outsource peer data processing, including paper-based summary and raw data processing integrated with web-based data.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Bionostics develops, formulates, manufactures, packages, and distributes proprietary device-specific quality control solutions, calibrators, and standards for in-vitro diagnostic (IVD) equipment used in critical care, point-of-care, and diabetes diagnostics. The company offers aqueous, plasma, and serum-based controls, buffers, calibrators and standards integrated into OEM diagnostic devices, plus direct-to-hospital products through its RNA Medical subsidiary. Operations span the full lifecycle from concept and regulatory submission through validated manufacturing with batch sizes from 15ml to 1000L.

Product overview

Bio-Techne (formerly Bionostics) offers a comprehensive portfolio of quality control and calibration solutions for IVD manufacturers, consisting of core product lines (UniDose containers, PeerQC peer statistics service, Quality Control Solutions, Meter Check, Safe-Wrap Blood Collection Tubes) and the RNA Medical sub-brand for hospital direct sales. The company provides turnkey solutions from formulation and development through manufacturing and distribution, serving both OEM customers and healthcare facilities. Services include technology transfer, product development, regulatory support, testing and analysis, and distribution logistics.

Differentiator

Problem solved

Functional benefit

Brands

• RNA Medical: Hospital direct sales distribution brand for quality control products, calibration verification materials, and blood collection tubes
• UniDose
• Meter Check
• PeerQC
• Safe-Wrap

Products and services

• Quality Control Solutions Proprietary device-specific calibration and quality control formulations for IVD manufacturers, including aqueous, plasma, and serum-based controls, buffers, calibrators, and standards optimized for stability, safety, and reliability on diagnostic systems. Targets IVD OEMs in critical care, point-of-care, and diabetes diagnostics.
• UniDose Container System Novel foil-based single-use control solution container designed for optimal stability and ease of use in point-of-care testing environments. Addresses open bottle stability concerns by providing sealed individual dose units that eliminate contamination risks and extend usability. Covered by US Patent 7,749,753 and US Patent 7,850,923.
• Meter Check Registered trademark control product for glucose meter verification, part of the UniDose packaging system designed to improve patient compliance and medical outcomes in diabetes point-of-care diagnostics.
• PeerQC Interlaboratory Peer Statistics Service Web-based interlaboratory peer statistics service enabling diagnostic customers to review quality control results in comparison with peer groups. Features patented error prevention technology and real-time peer data processing over the web.
• Safe-Wrap Blood Collection Tubes Heparinized glass capillary collection tubes with puncture-resistant Mylar covering that reduce risks associated with broken glass while utilizing preferred collection material for capillary blood gas samples. Distributed via the RNA Medical direct sales channel.
• RNA Medical Direct Sales Distribution Direct-to-hospital distribution channel offering daily QC materials, calibration verification and linearity products, and blood collection tubes for point-of-care diagnostics to hospitals and healthcare facilities worldwide.
• Distribution and Logistics Services Comprehensive distribution and logistics services including drop-ship capabilities, inventory management, and logistics support enabling efficient commercialization of quality control products for OEM customers.

Quantifiable outcome

• Speeds FDA approval and shortens development cycles for IVD manufacturers
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• RNA MedicalcoreStrategic or Co-development Partner · 1 January 1986Bio-Techne acquired RNA Medical in 1986, adding a direct-to-hospital product line for quality control and calibration verification materials. RNA Medical now functions as Bio-Techne's hospital direct sales distribution channel.

Scale indicators6 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Technopath Clinical Diagnostics: Independent manufacturer of third-party QC materials and calibration verification products for clinical chemistry and immunoassay, including the IA Plus and IA Strip lines. Directly comparable on IVD QC consumables sold into hospital and OEM channels.
• Streck: Develops and manufactures stabilised controls for hematology, flow cytometry, infectious disease molecular, and urinalysis. Directly comparable as a specialist IVD QC manufacturer with proprietary stabilised control formulations.
• Fortress Diagnostics: Manufactures clinical chemistry QC sera, calibrators, and specialty controls for IVD platforms, with direct overlap on hospital-direct sales channels analogous to Bio-Techne's RNA Medical arm.
• Bio-Rad Laboratories: Largest independent manufacturer of quality controls, calibrators, and proficiency testing materials for clinical chemistry, immunology, hematology, and molecular diagnostics (e.g., Liquichek, Lyphochek lines). Directly comparable as the category leader for IVD QC consumables that Bio-Techne serves.
• SERO (HemaXis): Manufactures independent clinical chemistry and immunology control sera (e.g., Autonorm, Immuno-Trol), directly overlapping with Bio-Techne's QC formulation business on the hospital/lab side of the market.
• LGC Group (Maine Standards / SeraCare): Through Maine Standards and SeraCare, LGC supplies calibration verification / linearity and disease-state QC materials for IVD OEMs and clinical labs. Directly comparable as a manufacturer of device-specific calibrators and validation materials for the same OEM channel.
• Randox Laboratories: Manufactures Acusera third-party QC sera and calibration verifiers for clinical chemistry and immunoassay, and offers RIQAS interlaboratory peer comparison software. Directly comparable on both IVD QC consumables and the peer-comparison service layer (PeerQC equivalent).

Broad incumbents

• Thermo Fisher Scientific: Through its Specialty Diagnostics and Analytical Instruments segments, supplies a broad portfolio of QC controls, reagents, and laboratory instrumentation. Overlaps with Bio-Techne in IVD QC consumables but as part of a much wider life-sciences portfolio.
• Merck KGaA (Life Science / Sigma-Aldrich): Supplies certified reference materials, standards, and laboratory QC products through its Life Science division. Overlaps with Bio-Techne on standards and reference materials but at a broader catalogue scale across many industries.
• Roche Diagnostics: Large IVD OEM that develops its own device-specific controls but also represents the type of OEM customer Bio-Techne serves. Adjacent competitor for in-house QC capabilities and benchmark for OEM channel economics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks4 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/bionostics

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bionostics